Header Logo

Connection

Theodore Levin to Cohort Studies

Back to Details
This is a "connection" page, showing publications Theodore Levin has written about Cohort Studies.
Theodore Levin
Connection Strength
0.561
Cohort Studies
  1. Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. BMC Cancer. 2018 May 02; 18(1):509.
    View in: PubMed
    Score: 0.100
  2. Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting. Gastrointest Endosc. 2018 Mar; 87(3):755-765.e1.
    View in: PubMed
    Score: 0.095
  3. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641.
    View in: PubMed
    Score: 0.093
  4. Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Netw Open. 2024 Jul 01; 7(7):e2421019.
    View in: PubMed
    Score: 0.038
  5. Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort. JAMA Netw Open. 2024 Apr 01; 7(4):e245295.
    View in: PubMed
    Score: 0.038
  6. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection. Ann Intern Med. 2019 05 21; 170(10):736-737.
    View in: PubMed
    Score: 0.027
  7. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med. 2016 11; 31(11):1323-1330.
    View in: PubMed
    Score: 0.022
  8. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8.
    View in: PubMed
    Score: 0.022
  9. Lack of significant association between serum inflammatory cytokine profiles and the presence of colorectal adenoma. BMC Cancer. 2015 Mar 14; 15:123.
    View in: PubMed
    Score: 0.020
  10. Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme. Gut. 2016 Feb; 65(2):271-7.
    View in: PubMed
    Score: 0.020
  11. Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46.
    View in: PubMed
    Score: 0.020
  12. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):172-80.
    View in: PubMed
    Score: 0.017
  13. Hepatic effects of lovastatin exposure in patients with liver disease: a retrospective cohort study. Drug Saf. 2008; 31(4):325-34.
    View in: PubMed
    Score: 0.012
  14. Medical therapy for diabetes is associated with increased use of lower endoscopy. Pharmacoepidemiol Drug Saf. 2007 Nov; 16(11):1195-202.
    View in: PubMed
    Score: 0.012
  15. The incidence of colorectal cancer following a negative screening sigmoidoscopy: implications for screening interval. Gastroenterology. 2004 Sep; 127(3):714-22.
    View in: PubMed
    Score: 0.010
  16. Gastric and duodenal safety of daily alendronate. Arch Intern Med. 2002 Apr 22; 162(8):936-42.
    View in: PubMed
    Score: 0.008
  17. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40.
    View in: PubMed
    Score: 0.008

© 2024 Kaiser Permanente